论文信息 - Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study - 字舞流文

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

A. Achiron | U. Givon | G. Harari | D. Magalashvili | M. Gurevich | R. Zilkha-Falb | S. Flechter | M. Mandel | S. Menascu | M. Dolev | Polina Sonis | Diana Guber | S. Dreyer-Alster | D. Guber